8.7
/ 10
HIGH
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N
Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
AI Analysis
Use of client-side authentication vulnerability in NMIS/BioDose V22.02 and previous versions
Basic Information
ID
CVE-2025-61940
Source
icscert
Published
Dec 2, 2025 at 21:07
Modified
Dec 2, 2025 at 21:39
Affected Product
Vendor
Mirion Medical
Product
EC2 Software NMIS BioDose
Affected Versions
Mirion Medical EC2 Software NMIS BioDose 0
CWE Classification
AI Assessment
AI Score
8.7 / 10
AI Severity
High
Vendor
Mirion Medical
Product
NMIS/BioDose
Version
V22.02 and previous versions